Copyright Reports & Markets. All rights reserved.

Global Antibiotic Resistance Market Research Report 2021

Request for Sample of this report
Buy now

1 Antibiotic Resistance Market Overview

  • 1.1 Product Overview and Scope of Antibiotic Resistance
  • 1.2 Antibiotic Resistance Segment By Disease
    • 1.2.1 Global Antibiotic Resistance Sales Growth Rate Comparison By Disease (2021-2027)
  • 1.3 Antibiotic Resistance Segment by Application
    • 1.3.1 Antibiotic Resistance Sales Comparison by Application: (2021-2027)
    • 1.3.2 Oxazolidinones
    • 1.3.3 Lipoglycopeptides
    • 1.3.4 Tetracyclines
    • 1.3.5 Cephalosporins
    • 1.3.6 Combination therapies
    • 1.3.7 Other
  • 1.4 Global Antibiotic Resistance Market Size Estimates and Forecasts
    • 1.4.1 Global Antibiotic Resistance Revenue 2016-2027
    • 1.4.2 Global Antibiotic Resistance Sales 2016-2027
    • 1.4.3 Antibiotic Resistance Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antibiotic Resistance Market Competition by Manufacturers

  • 2.1 Global Antibiotic Resistance Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Antibiotic Resistance Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Antibiotic Resistance Manufacturing Sites, Area Served, Product Type
  • 2.5 Antibiotic Resistance Market Competitive Situation and Trends
    • 2.5.1 Antibiotic Resistance Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Antibiotic Resistance Players Market Share by Revenue
    • 2.5.3 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antibiotic Resistance Retrospective Market Scenario by Region

  • 3.1 Global Antibiotic Resistance Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Antibiotic Resistance Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Antibiotic Resistance Market Facts & Figures by Country
    • 3.3.1 North America Antibiotic Resistance Sales by Country
    • 3.3.2 North America Antibiotic Resistance Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Antibiotic Resistance Market Facts & Figures by Country
    • 3.4.1 Europe Antibiotic Resistance Sales by Country
    • 3.4.2 Europe Antibiotic Resistance Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Antibiotic Resistance Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Antibiotic Resistance Sales by Region
    • 3.5.2 Asia Pacific Antibiotic Resistance Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Antibiotic Resistance Market Facts & Figures by Country
    • 3.6.1 Latin America Antibiotic Resistance Sales by Country
    • 3.6.2 Latin America Antibiotic Resistance Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Antibiotic Resistance Sales by Country
    • 3.7.2 Middle East and Africa Antibiotic Resistance Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Antibiotic Resistance Historic Market Analysis by Type

  • 4.1 Global Antibiotic Resistance Sales Market Share by Type (2016-2021)
  • 4.2 Global Antibiotic Resistance Revenue Market Share by Type (2016-2021)
  • 4.3 Global Antibiotic Resistance Price by Type (2016-2021)

5 Global Antibiotic Resistance Historic Market Analysis by Application

  • 5.1 Global Antibiotic Resistance Sales Market Share by Application (2016-2021)
  • 5.2 Global Antibiotic Resistance Revenue Market Share by Application (2016-2021)
  • 5.3 Global Antibiotic Resistance Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Allergan
    • 6.1.1 Allergan Corporation Information
    • 6.1.2 Allergan Description and Business Overview
    • 6.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Allergan Product Portfolio
    • 6.1.5 Allergan Recent Developments/Updates
  • 6.2 AmpliPhi Biosciences
    • 6.2.1 AmpliPhi Biosciences Corporation Information
    • 6.2.2 AmpliPhi Biosciences Description and Business Overview
    • 6.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 AmpliPhi Biosciences Product Portfolio
    • 6.2.5 AmpliPhi Biosciences Recent Developments/Updates
  • 6.3 BioVersys GmbH
    • 6.3.1 BioVersys GmbH Corporation Information
    • 6.3.2 BioVersys GmbH Description and Business Overview
    • 6.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 BioVersys GmbH Product Portfolio
    • 6.3.5 BioVersys GmbH Recent Developments/Updates
  • 6.4 Macrolide Pharmaceuticals
    • 6.4.1 Macrolide Pharmaceuticals Corporation Information
    • 6.4.2 Macrolide Pharmaceuticals Description and Business Overview
    • 6.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Macrolide Pharmaceuticals Product Portfolio
    • 6.4.5 Macrolide Pharmaceuticals Recent Developments/Updates
  • 6.5 Melinta Therapeutics
    • 6.5.1 Melinta Therapeutics Corporation Information
    • 6.5.2 Melinta Therapeutics Description and Business Overview
    • 6.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Melinta Therapeutics Product Portfolio
    • 6.5.5 Melinta Therapeutics Recent Developments/Updates
  • 6.6 Merck
    • 6.6.1 Merck Corporation Information
    • 6.6.2 Merck Description and Business Overview
    • 6.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Merck Product Portfolio
    • 6.6.5 Merck Recent Developments/Updates
  • 6.7 Nabriva Therapeutics
    • 6.6.1 Nabriva Therapeutics Corporation Information
    • 6.6.2 Nabriva Therapeutics Description and Business Overview
    • 6.6.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Nabriva Therapeutics Product Portfolio
    • 6.7.5 Nabriva Therapeutics Recent Developments/Updates
  • 6.8 Nemesis Bioscience
    • 6.8.1 Nemesis Bioscience Corporation Information
    • 6.8.2 Nemesis Bioscience Description and Business Overview
    • 6.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Nemesis Bioscience Product Portfolio
    • 6.8.5 Nemesis Bioscience Recent Developments/Updates
  • 6.9 Phage Technologies S.A
    • 6.9.1 Phage Technologies S.A Corporation Information
    • 6.9.2 Phage Technologies S.A Description and Business Overview
    • 6.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Phage Technologies S.A Product Portfolio
    • 6.9.5 Phage Technologies S.A Recent Developments/Updates
  • 6.10 Tetraphase Pharmaceuticals
    • 6.10.1 Tetraphase Pharmaceuticals Corporation Information
    • 6.10.2 Tetraphase Pharmaceuticals Description and Business Overview
    • 6.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Tetraphase Pharmaceuticals Product Portfolio
    • 6.10.5 Tetraphase Pharmaceuticals Recent Developments/Updates
  • 6.11 The Medicines Company
    • 6.11.1 The Medicines Company Corporation Information
    • 6.11.2 The Medicines Company Antibiotic Resistance Description and Business Overview
    • 6.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 The Medicines Company Product Portfolio
    • 6.11.5 The Medicines Company Recent Developments/Updates
  • 6.12 TPfizer
    • 6.12.1 TPfizer Corporation Information
    • 6.12.2 TPfizer Antibiotic Resistance Description and Business Overview
    • 6.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 TPfizer Product Portfolio
    • 6.12.5 TPfizer Recent Developments/Updates
  • 6.13 Westway Health
    • 6.13.1 Westway Health Corporation Information
    • 6.13.2 Westway Health Antibiotic Resistance Description and Business Overview
    • 6.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Westway Health Product Portfolio
    • 6.13.5 Westway Health Recent Developments/Updates

7 Antibiotic Resistance Manufacturing Cost Analysis

  • 7.1 Antibiotic Resistance Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Antibiotic Resistance
  • 7.4 Antibiotic Resistance Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Antibiotic Resistance Distributors List
  • 8.3 Antibiotic Resistance Customers

9 Antibiotic Resistance Market Dynamics

  • 9.1 Antibiotic Resistance Industry Trends
  • 9.2 Antibiotic Resistance Growth Drivers
  • 9.3 Antibiotic Resistance Market Challenges
  • 9.4 Antibiotic Resistance Market Restraints

10 Global Market Forecast

  • 10.1 Antibiotic Resistance Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Antibiotic Resistance by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Antibiotic Resistance by Type (2022-2027)
  • 10.2 Antibiotic Resistance Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Antibiotic Resistance by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Antibiotic Resistance by Application (2022-2027)
  • 10.3 Antibiotic Resistance Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Antibiotic Resistance by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Antibiotic Resistance by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    By Disease
    By Pathogen

    Segment by Application
    Oxazolidinones
    Lipoglycopeptides
    Tetracyclines
    Cephalosporins
    Combination therapies
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Allergan
    AmpliPhi Biosciences
    BioVersys GmbH
    Macrolide Pharmaceuticals
    Melinta Therapeutics
    Merck
    Nabriva Therapeutics
    Nemesis Bioscience
    Phage Technologies S.A
    Tetraphase Pharmaceuticals
    The Medicines Company
    TPfizer
    Westway Health

    Buy now